- XII Curso Internacional de Epidemiologia Molecular das Doenças Infecciosas - 5 a 10 agosto 2012 - II Simpósio de Gestão de Projetos Aplicada à Pesquisa Científica - 09 a 10 agosto 2012 - V Encontro Nacional de Educação Popular em Saúde - 31 julho a 03 agosto 2012 - 10º Congresso Internacional de Biologia Celular - 25 a 28 julho 2012
(1) PATHIL, A. et al. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Hepatology, Baltimore, v. 55, n. 5, p. 1369-1378, May 2012.
(2) FRIEDMAN, S. L. Focus: an emerging conceptual scaffold for NASH. Journal of hepatology, Amsterdam, v. 56, n. 3, p. 511-512, Mar. 2012. (3) Lee, Y. S; Jeong, W. I. Retinoic acids and hepatic stellate cells in liver disease. Journal of gastroenterology and hepatology, Melbourne, v. 27, p. 75-79, Mar. 2012. Supplement 2. (4) LEE, J. A.; PAYETTE, M.; OSIECKI, J. Viral hepatitis: targeted tests and therapies contribute to improved outcomes. MLO medical laboratory observer, v. 44, n. 3, p. 18-20, Mar. 2012. (5) PRICE, J. C. et al. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. Journal of infectious diseases, Chicago, v. 205, n. 6, p. 1005-10013, Mar. 2012. (6) ZIERDEN, M. et al. Keratin 8 variants are associated with cryptogenic hepatitis. Virchows archiv, Berlin, v. 460, n. 4, p. 389-397, Apr. 2012. (7) SAUER, V et al. Repeated transplantation of hepatocytes prevents fulminant hepatitis in a rat model of Wilson's disease. Liver transplantation, Philadelphia, v. 18, n. 2, p. 248-259, Feb. 2012. (8) FINLAY, L. A. et al. R-α-lipoic acid does not reverse hepatic inflammation of aging, but lowers lipid anabolism, while accentuating circadian rhythm transcript profiles. American journal of physiology, Bethesda, v. 302, n. 5, p. R587-597, Mar. 2012. (9) VANDERHEYDEN, T. R. et al. Granulomatous hepatitis due to Bartonella henselae infection in an immunocompetent patient. BMC infectious diseases, London, v. 12, p. 17, 2012. (10) AL-QURAISHY, S. et al. Liver response of rabbits to Eimeria coecicola infections. Parasitology research, Berlin, v. 110, n. 2, p. 901-911, Feb. 2012.
TRACOMA (1) TAYLOR, H. R. et al. Prevalence of trachoma in a single community, 1975-2007. RAJAK, S. N.; COLLIN, J. R.; BURTON , M. J. Trachomatous trichiasis and its management in endemic countries. Survey of ophthalmology, Boston, v. 57, n. 2, p. 105-35, Mar.-Apr.2012 . (3) HU, V. H.; et al. Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma. Infection and immunity, Washington, v. 80, n. 1, p. 121-130, Jan. 2012. (4) RABIU, M. ; ALHASSAN, M. B.; EJERE, H. O. D.; EVANS, J. R. Environmental sanitary interventions for preventing active trachoma. Cochrane Database of Systematic Reviews; n. 5, CD004003, 2012. (5) .
Clinical & Experimental Ophthalmology, Carlton, v. 40, n. 2, p. 121-126, Mar. 2012 .
(2)
Leia o artigo
HARRIS SR; et al. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nature genetics, New York, v. 44, n.4, p. 413-419, S1, Apr. 2012.
(1) MACKEY, T. K.; LIA, B. A. Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property. Drug discovery today, Oxford, June, 2012. (2) ANFRAY, C.; EMERY, M.P.; CONWAY, K.; ACQUADRO, C. Questions of copyright. Health and quality of life outcomes, London, v.10, p.16, 2012. (3) TAYLOR, M. R.Innovation under cap-and-trade programs.Proceedings of the National Academy of Sciences of the United States of America, v. 109, n. 13, p. 4804-4809, Mar 2012. (4) RUTZ, B. From bench to market: life science patents in Europe. Biotechnology Joournal, v. 7, n. 2, p. 171-175, Feb. 2012. (5) PENTLAND, A. P.; CONNOLLY, N.L.; FAHNER-VIHTELIC, J. E. Patents and growth. Journal of investigative dermatology, Baltimore, v. 132, n. 3 pt 2, p. 1037-1041, Mar. 2012. 
Projeto Original
Conceição Carvalho - conceicao.carvalho@icict.fiocruz.br
Diones Ramos - diones.ramos@icict.fiocruz.br
Fátima Duarte - fatima.duarte@icict.fiocruz.br
Mônica Garcia - monica.garcia@icict.fiocruz.br
Rafael Cavadas - rcavadas@icict.fiocruz.br
Michele Nogueira -
Fernando Proença - fernando.proenca@icict.fiocruz.br
Programação Visual
Marcelo Vasconcellos - marcelo.vasconcellos@icict.fiocruz.br
Revisão de Conteúdo
Cristiane d'Avila - cristiane.davila@icict.fiocruz.br
Graça Portela - graca.portela@icict.fiocruz.br
Desenvolvimento de Sistema
Rosicler Magalhães- rosicler.magalhaes@icict.fiocruz.br
